Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/14/2023
CDE Issues the Technical Guidelines for Research on Quality Attributes...
2/14/2023
CDE Seeks Comments on Draft ICH Guidelines M13A
2/14/2023
Hengrui and Treeline Enter $706M Licensing Deal for EZH2 inhibitor SHR...
2/14/2023
Cullinan and HBM Sign Licensing Deal for B7H4 x 4-1BB Bispecific Immu...
2/14/2023
CDE Issues the Guidelines for Clinical Evaluation of Radioactive In Vi...
2/13/2023
Nona Biosciences Enters into HCAb Based Antibody Discovery Collaborati...
2/13/2023
Lantheus Acquires Cerveau and Its Tau-spotting PET Tracer for Alzheime...
2/13/2023
CDE Issues the Guidelines for Clinical Development of New Drugs for Ac...
2/13/2023
CDE Issues the Guidelines for Clinical Trials of Drug Therapies for Pr...
2/13/2023
CDE Issues the Guidelines for Pharmaceutical Study and Assessment of O...
2/13/2023
Corbus Licenses Clinical Stage Nectin-4 Targeting ADC from CSPC Megal...
2/13/2023
Clover Launches COVID-19 Booster Vaccine in China
2/10/2023
China Drug Sales Performance of Top Seven MNC Pharma Cos in 2022
2/10/2023
Recent Executive Moves
2/10/2023
Drug R&D and Product Registration News Digest February 2023 (2)
2/10/2023
Six Central Government Agencies Introduce the Work Plan for Trial of C...
2/10/2023
U.S. Aims to Curtail Technology Investment in China (NYT)
2/9/2023
Facing Multiple Challenges, What Are the Clinical Development Trends i...
2/9/2023
With China's Re-opening: Staying Ahead of FDA Drug cGMP Enforcement (G...
2/9/2023
It Is Now More Difficult For International Pharma To Transfer Data Out...
2/9/2023
Amid Scarcity and Soaring Prices, China Could Issues Compulsory Licens...
2/8/2023
After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
2/8/2023
ReviR and Asieris Enter into Agreement to Discover Oncology Therapeut...
2/7/2023
New-Generation Long-Acting Growth Hormone Is A Potential Game Changer ...
2/7/2023
China's 2022 NRDL Readout (PharmExec)
2/6/2023
Ji Xing Acquires Global Rights of PhaseBio's CVD Drug PB6440
2/3/2023
Recent Executive Moves
2/3/2023
Drug R&D and Product Registration News Digest February 2023 (1)
2/2/2023
NMPA Holds National Drug Registration and Post-Marketing Supervision C...
2/2/2023
Huawei to Build First Digital Robot for Pharmaceutical Industry
Page:
56
/
719
Total number of articles:
21546
:
[First]
[<<]
[54]
[55]
[56]
[57]
[58]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit